The 'Healthy Mum, Healthy Baby, Healthy Future' report from the University of Birmingham sets out the case for developing more medicines for use in pregnancy.
Pharmaceutical companies are already working as part of global research initiatives to generate reliable evidence on medicines used during pregnancy. Steve Hoare, ABPI Director of Quality, Regulatory Science and Safety Policy
In response, Steve Hoare, the ABPI's Director of Quality, Regulatory Science & Safety Policy, said:
“It’s clear that much more needs to be done to improve the treatment options available to pregnant women.
“Pharmaceutical companies are already working as part of global research initiatives to generate reliable evidence on medicines used during pregnancy.
"As part of this, we are committed to working with Government, regulators and the wider life sciences sector to put the constructive solutions of this report into practice.”
Read the report at Birmingham Health Partners- Clinical research
Last modified: 12 May 2022
Last reviewed: 12 May 2022